Insulin Resistance Intervention After Stroke Trial

Trial ID or NCT#

NCT00091949

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.

Official Title

Insulin Resistance Intervention After Stroke (IRIS) Trial

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Contact us to find out if this trial is right for you.

Contact

Madelleine Garcia
6507252326

View on ClinicalTrials.gov